27 August 2015
With an initial investment of BRL $20 million (approximately CAD $8 million) in equipment, facilities and technical staff, Biolab Farmacêutica, a 100 per cent Brazilian-owned company that ranks among the largest in the healthcare market in Brazil, announced the opening of a Research and Development (R&D) Centre in the Greater Toronto Area. This investment is part of Biolab's global expansion plans. In the initial stage, 20 specialized professionals will work in the new facility. The 1,000 square meter R&D centre will be an extension of Biolab's Itapecerica da Serra R&D centre in Brazil, and the two operations will be fully integrated.
Click here for full article.